Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours Β· Estimated delivery Aug 29 - Sep 3
Protect your health
Typical side effects include queasiness and stomach upset
Our experienced staff will answer all your questions and concerns and help you throughout your weight loss journey
The treatment discontinuation rate due to adverse events was low at 5.9% in CT-388 arms vs 1.3% in placebo
PlexusDx offers both medications separately and combined in the GLP-Squared dual-compound injection protocol ($289/month), allowing patients and providers to select the approach matching their genetic predispositions and clinical history
Retatrutide vs Tirzepatide Retatrutide, a first-in-class triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors, demonstrates unprecedented weight loss efficacy in clinical trialsup to 24.2% body weight reduction at 48 weeks
US$ 23.40
US$ 25.20
US$ 23.35
US$ 25.79
US$ 25.00
